JPWO2020184729A1 - - Google Patents

Info

Publication number
JPWO2020184729A1
JPWO2020184729A1 JP2021505167A JP2021505167A JPWO2020184729A1 JP WO2020184729 A1 JPWO2020184729 A1 JP WO2020184729A1 JP 2021505167 A JP2021505167 A JP 2021505167A JP 2021505167 A JP2021505167 A JP 2021505167A JP WO2020184729 A1 JPWO2020184729 A1 JP WO2020184729A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505167A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020184729A1 publication Critical patent/JPWO2020184729A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021505167A 2019-03-14 2020-03-13 Pending JPWO2020184729A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019046572 2019-03-14
PCT/JP2020/012566 WO2020184729A1 (ja) 2019-03-14 2020-03-13 筋萎縮性側索硬化症の治療用医薬組成物

Publications (1)

Publication Number Publication Date
JPWO2020184729A1 true JPWO2020184729A1 (ja) 2020-09-17

Family

ID=72426891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505167A Pending JPWO2020184729A1 (ja) 2019-03-14 2020-03-13

Country Status (10)

Country Link
US (1) US20220133805A1 (ja)
EP (1) EP3939660A4 (ja)
JP (1) JPWO2020184729A1 (ja)
KR (1) KR20210138655A (ja)
CN (1) CN113557025A (ja)
AU (1) AU2020236160A1 (ja)
CA (1) CA3133038A1 (ja)
IL (1) IL286321A (ja)
SG (1) SG11202110033UA (ja)
WO (1) WO2020184729A1 (ja)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9682319B2 (en) 2002-07-31 2017-06-20 Sony Interactive Entertainment Inc. Combiner method for altering game gearing
WO2009034708A1 (ja) 2007-09-11 2009-03-19 Sapporo Medical University 細胞増殖方法ならびに組織の修復および再生のための医薬
PT2785359T (pt) 2011-11-30 2018-11-06 Astellas Inst For Regenerative Medicine Células estromais mesenquimatosas e usos relacionados com as mesmas
DK2880151T3 (da) 2012-08-06 2020-08-17 Brainstorm Cell Therapeutics Ltd Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
SG11201809512TA (en) 2016-04-28 2018-11-29 Univ Sapporo Medical Synapse formation agent
CA3033408A1 (en) * 2016-07-18 2018-01-25 Brainstorm Cell Therapeutics Ltd Methods for treating amyotrophic lateral sclerosis (als)
EP3501525A4 (en) 2016-08-18 2020-04-08 Sapporo Medical University LIFETIME EXTENSION AGENT
CA3042360A1 (en) * 2016-11-03 2018-05-11 Exostem Biotec Ltd. Mesenchymal stem cells populations, their products, and use thereof
JP6942565B2 (ja) 2017-08-30 2021-09-29 京セラ株式会社 発電装置、制御装置及び制御プログラム

Also Published As

Publication number Publication date
CA3133038A1 (en) 2020-09-17
US20220133805A1 (en) 2022-05-05
SG11202110033UA (en) 2021-10-28
IL286321A (en) 2021-10-31
EP3939660A1 (en) 2022-01-19
AU2020236160A1 (en) 2021-09-16
WO2020184729A1 (ja) 2020-09-17
EP3939660A4 (en) 2022-12-28
KR20210138655A (ko) 2021-11-19
CN113557025A (zh) 2021-10-26

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021013854A2 (ja)
BR112019016141A2 (ja)
AU2020104490A4 (ja)
BR112021017738A2 (ja)
BR112019016142A2 (ja)
BR112021008711A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021018484A2 (ja)
BR112021017732A2 (ja)
BR112021015080A2 (ja)
BR112021016996A2 (ja)
BR112021017010A2 (ja)
AT524962A5 (ja)
BR112019016136A2 (ja)
BR112021016821A2 (ja)
JPWO2020184729A1 (ja)
BR112021016784A2 (ja)
BR112021016979A2 (ja)
BR112021016205A2 (ja)
BR112021016099A2 (ja)
BR102019023359A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240425